StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TDAC

Translational Development Acquisition Corp.

TDACW Nasdaq Blank Checks EDGAR ↗
$1.50
-0.03 -1.96%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
—
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
$5.54M
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
$85.9K
Total assets ⓘ
$157M
Gross margin ⓘ
—
52-week range ⓘ
$1.49 – $1.50

AI briefing

from the latest 10-K, 10-Q and 8-K events

TDAC is a Nasdaq-listed Cayman Islands blank check company that has not yet completed a business combination and is currently pursuing a merger with ProLogium Holding Inc.

What they do

TDAC is a special purpose acquisition company formed on April 19, 2022 for the purpose of effecting a merger or similar business combination with one or more businesses. It has no operating business of its own and holds proceeds from its IPO and private placement warrants in trust. On May 27, 2026, it entered a Business Combination Agreement with ProLogium Holding Inc. and two merger subsidiaries.

Revenue drivers

  • Trust account interest income — The company holds IPO proceeds in trust; the 2025 net income of $6.4 million reflects non-operating income earned on those investments, not operating revenue.
  • No operating segments — As a blank check company, TDAC has no products, customers or operating revenue; its results are driven by trust earnings and formation/operating expenses.

Recent performance

For the year ended December 31, 2025, TDAC reported net income of $6.4 million, compared with a net loss of $71,012 in 2024 and a net loss of $485,550 in 2023. Operating cash flow was negative $608,387 in 2025, versus negative $851,446 in 2024 and negative $204 in 2023. At June 30, 2026, total assets were $157.4 million, total liabilities were $7.8 million, shareholders' equity was negative $7.7 million, and cash and equivalents were only $85,877. The 10-K/A filed May 11, 2026 revised management's conclusion to state that disclosure controls and procedures were not effective as of December 31, 2025.

Strategy

The company's stated direction is to consummate the ProLogium Business Combination announced May 27, 2026, structured as two successive mergers that would make TDAC a wholly-owned subsidiary of ProLogium. On July 27, 2026, TDAC and ProLogium entered a subscription agreement with Naetas Holding Limited to purchase 5,000,000 Class A ordinary shares at $10.00 per share for $50.0 million, with an equal number of warrants issued for no additional consideration. The subscription is expected to close one business day before the business combination closes. TDAC has also filed 8-Ks in June 2026 covering a shareholder vote, charter amendment, and unregistered equity sales.

Risks

  • Business combination may not close — The ProLogium transaction is subject to conditions; the 10-Q notes the possibility that conditions of the business combination are not satisfied.
  • Going-concern and liquidity risk — At June 30, 2026, cash and equivalents were only $85,877 against $7.8 million of liabilities and negative $7.7 million shareholders' equity.
  • Redeemable share overhang — As a blank check company with a trust structure, redemptions by public shareholders could reduce cash available to the combined company at closing.
  • Disclosure controls found ineffective — The 10-K/A states that disclosure controls and procedures were not effective as of December 31, 2025.

Outlook

Management states it expects to continue incurring significant costs pursuing its acquisition plans and cannot assure that its plans to complete an initial business combination will be successful. The near-term path depends on closing the ProLogium Business Combination and the $50.0 million Naetas subscription. No operating results are guided because the company has no operating business.

Recent SEC filings

40 most recent
Annual, quarterly & current reports
Other filings
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 12, 2026
SCHEDULE 13G/A Jul 16, 2026
SCHEDULE 13G Jun 2, 2026